ArticleBMC musculoskeletal disorders2022
Factors associated with the relapse in Ponseti treated congenital clubfoot.
Article in BMC musculoskeletal disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05957627 (Effect of Saleem's Protocol on Foot Deformity in Congenital Talipes Equinovarus), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of Saleem's Protocol on Foot Deformity in Congenital Talipes Equinovarus
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.
- Global prevalence, patterns, and predictors of relapse following Ponseti treatment for idiopathic clubfoot: a systematic review and meta-analysis.BMC musculoskeletal disorders · 2026Pooled it
- Management of idiopathic clubfoot: an umbrella review and CPAM-LRC consensus: Limb Reconstruction Committee of Orthopedics Branch of China International Exchange and Promotion Association for Medical and Health Care (CPAM-LRC).Journal of orthopaedic surgery and research · 2025Pooled it
- Establishing the UK clubfoot research priorities : a multiple-stakeholder consensus study.Bone & joint open · 2026Article
- Health-related quality of life and caregiving burden in pediatric clubfoot patients treated with Ponseti method in China: a cross-sectional study.BMC musculoskeletal disorders · 2026Article
- Risk Factors for Relapse and Surgical Intervention in Children with CTEV Treated by Ponseti Method.Life (Basel, Switzerland) · 2026Article
- When Does Brace Noncompliance Occur in Patients with Clubfoot Deformity?Clinics in orthopedic surgery · 2025Observational
- Genetics, epidemiology and management of clubfoot and related disorders.Genes & diseases · 2025Review
- 3D Gait Analysis of Children Treated for Idiopathic Congenital Talipes Equinovarus After Completion of Ponseti Treatment.Indian journal of orthopaedics · 2025Review
- The potential of machine learning in classifying relapse and non-relapse in children with clubfoot based on movement patterns.Scientific reports · 2025Article
- Congenital Clubfoot: Difficulties in Maintaining the Use of the Dennis-Brown Orthosis by Caregivers.Revista brasileira de ortopedia · 2024Article
- Assessment of Treatment Outcomes in the Management of Club foot using the Ponseti Technique: A cross-sectional study.African journal of paediatric surgery : AJPS · 2024Article
- Article
- Parental Concerns Regarding Bracing Compliance for Children With Clubfoot: Seeking Support on Facebook.Cureus · 2023Article
- Exploring Bracing Adherence in Ponseti Treatment of Clubfoot: A Comparative Study of Factors and Outcomes in Uganda.International journal of environmental research and public health · 2023Article
- A 5-years results of the Ponseti method in the treatment of congenital clubfoot: a retrospective study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023Article
- Kinematic Gait Impairments in Children with Clubfeet Treated by the Ponseti Method: A Systematic Review and Meta-Analysis.Children (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWe retrospectively investigated the clinical materials to seek the factors that lead to relapse after using the Ponseti method.
methodsWe retrospectively reviewed all children with congenital clubfoot treated with the Ponseti method in our hospital from June 2008 to June 2013. The data included the following factors: age, gender, initial Pinari score, number of casts, number of feet (unilateral or bilateral), age at the first casting, age of mother, tenotomy, walking age, and compliance with using bracing. All investigations were conducted in conformity with ethical standards. This study was approved by Guilin Peoples' Hospital Ethics Committee.
resultsIn this study, there were 148 cases (164 ft) in total that underwent the Ponseti method, with the follow-up period at least 5 years. Of them, 64 children presented with left side, 58 with right side, and 26 with bilateral cases. This study included 75 males and 73 females; sex did not affect the outcomes. The mean age of the first casting was 2.50 ± 2.15 months. The average initial Pirani score was 4.98 ± 1.33, and the average number of casts was 5.71 ± 2.28 times. The mean age of mothers at birth was 25.81 ± 2.38 years old. The walking age of children was at a mean of 14.83 ± 1.18 months. Forty-nine cases could not tolerate using braces, namely the rate of noncompliance in this study was 33.1%. Tenotomy was performed on 113 ft (76.4%). The average follow-up period was 7.27 ± 1.29 years (from 5 to 10 years). The rate of relapse was 21.6% (32 cases) at the end of the follow-up. The rate of relapse in the noncompliance with using bracing group was significantly higher compared to the compliance group .
conclusionThe initial Pirani score, compliance with the foot abduction brace and the age at the first casting are three independent factors for relapse in clubfoot.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.